abstract |
The present invention relates generally to a series of compounds, pharmaceutical compositions containing the compounds and uses of the compounds and compositions as therapeutic agents. More particularly, the compounds of the present invention are thiophenyl and pyrrolylazepine compounds. These compounds are serotonin receptor (5-HT2c) ligands and are useful for the treatment of diseases, disorders and diseases such as poisoning, anxiety, depression, obesity etc. in which the activity of the serotonin receptor (5-HT2c) . |